baber/WOPTO huggingface dataset:
Patent NZ-240732-A (NZ)
Title: Chair with locking mechanism to lock detachable seat back to chair frame.
Inventor: LA POINTE LARRY PATRICK
IPC: A47C4/02
Filed: 1991-11-26
Abstract: An improved locking mechanism for detachably securing a seat back (18) to a chair frame is disclosed. The improved locking mechanism includes a pair of slide brackets (54) secured to opposite sides of the seat back (18). Linkages (20) supported from the chair frame are provided for receiving the slide brackets (54) thereon for supporting the seat back (18) on the chair frame in a predetermined orientation relative to the seat member. A moveable locking arm (72) is supported from the slide brackets (54) and includes an offset arcuate cam surface (75) which is adapted to engage an arcuate notch (76) formed on the linkage (20) when the locking arm (72) is moved to a locked position. The mating engagement of the arcuate offset cam surface (75) within the arcuate notch (76) generates a line-of-contact therebetween which inhibits relative movement between the slide brackets (54) and the upstanding links (20) for rigidly securing seat member to the chair frame. An alternative embodiment discloses a modified link member which is adapted to create an interference engagement with the slide bracket (54) to augment the locking action of the arcuate cam surface (75) within the arcuate notch (76). <IMAGE>
Patent NZ-256076-A (NZ)
Title: Detection of bacteria involving bacteriophages, test kits therefor
Inventor: SANDERS MICHAEL FREDERICK
IPC: C12Q1/689
Filed: 1993-09-22
Abstract: A method for detection, identification and/or quantification of target organisms of specific bacterial genus, species or serotype, based upon the occurrence of release of cell contents, particularly nucleotides e.g. ATP, on lysis of bacterial cell walls on incubation with bacteriophages (phages) specific for them. When new phage particles are released at the end of the phage replication cycle nucleotide levels are measured and compared with controls. The method provides for the detection of specific bacteria in which insertion of the lux gene into the phage genome is not required yet it is faster and more sensitive than known non-modified phage utilising techniques. The method is only limited by the availability of phage types suitable for selective attack of the target bacteria to be detected and can detect a single Salmonella in a sample of milk in under 12 hours.
Patent NZ-275915-A (NZ)
Title: 4-phenyl substituted dihydropyridine 3,5-dicarboxylic acid ester derivatives and medicaments
Inventor: ANDERSSON KJELL HJALMAR
IPC: A61P9/12
Filed: 1994-11-03
Abstract: PCT No. PCT/SE94/01031 Sec. 371 Date Dec. 14, 1994 Sec. 102(e) Date Dec. 14, 1994 PCT Filed Nov. 3, 1994 PCT Pub. No. WO95/12578 PCT Pub. Date May 11, 1995Compounds of the general formula    <IMAGE>  I  wherein R1 and R2 are independently selected from the group consisting of hydrogen, chloro, bromo, nitro, cyano, trifluoromethyl, and R3 and R4 are independently selected from straight or branched lower (1-5 carbon atoms) alkyl groups, and including all optical isomers, provided that when R3 is methyl and R4 is tert.-butyl, then R1/R2 are not hydrogen/hydrogen, hydrogen/2'-trifluormethyl, 2'-chloro/3'-chloro, and when R3 is methyl and R1/R2 is hydrogen/3'-nitro, then R4 are not methyl, ethyl, propyl, iso-propyl, tert.-butyl, processes for their preparation, pharmaceutical preparations containing them and the use of the compounds in lowering the blood pressure.
Patent NZ-284182-A (NZ)
Title: Manufacture of diaper or sanitary panty: folded band of flexible material between side parts of folded blank
Inventor: KLING ROBERT
IPC: A61F13/15
Filed: 1995-04-11
Abstract: A method of manufacturing an absorbent article, and an absorbent article, in the form of a pants-type diaper or a sanitary panty, starting from a flat blank which includes an elongated absorbent body enclosed between two casing sheets which at opposing front and rear end parts of the absorbent body have side parts which extend laterally beyond the body on both sides thereof. The method includes the step of folding the blank around a transverse axis so that the end edges of the side parts lie edge-to-edge. At least one folded band of flexible material is placed between each pair of front and rear side parts which lie opposite one another in the folded state of the blank, and the free ends of the bands are fastened to adjacent side parts.
Patent NZ-284434-A (NZ)
Title: Use of heparin binding protein to prevent lps-induced cytokine cascade during sepsis
Inventor: FLODGAARD HANS JAKOB HEM
IPC: C12R1/91
Filed: 1995-03-17
Abstract: Pharmaceutical composition for the prevention or treatment of diseases or conditions associated with induction of the cytokine cascade by lipopolysaccharide (LPS), the composition comprising a heparin-binding protein (HBP) which, in glycosylated form, has an apparent molecular weight of 28 kD (as determined by SDS-PAGE under reducing conditions), the protein being produced in the azurophil granules of polymorphonuclear leukocytes, together with a pharmaceutically acceptable carrier or diluent. The heparin-binding protein is produced in host cells containing a DNA sequence encoding N-terminally extended HBP or encoding HBP preceded by and fused to a DNA sequence encoding another protein. Also disclosed is a process wherein the culture medium contains a sulphated polysaccharide.
Patent NZ-287284-A (NZ)
Title: N-[2-(phenyl(substituted)ethylamino)-1-(indolylmethyl)-1-methyl -2-oxoethyl] carbamic acid ester derivatives, medicaments and intermediates
Inventor: HORWELL DAVID CHRISTOPHER
IPC: A61K31/403
Filed: 1995-05-18
Abstract: The invention concerns tachykinin antagonists. The compounds are alcohols, amines and prodrugs of nonpeptides which have utility in treating disorders mediated by tachykinins. Such disorders are respiratory, inflammatory, gastrointestinal, ophthalmic, allergies, pain, vascular, diseases of the central nervous system, and migraine. Methods of preparing compounds and novel intermediates are also included. The compounds are expected to be especially useful in asthma, multiple sclerosis, rheumatoid arthritis, the management of pain, migraine, and antiemetic agents.
Patent NZ-288615-A (NZ)
Title: Aqueous fatty alcohol dispersions containing nonionic surfactant that is the reaction product of ethylene oxide and a 1,2-alkane diol
Inventor: WOLLENWEBER HORST-WERNER
IPC: C09K23/00
Filed: 1995-06-12
Abstract: PCT No. PCT/EP95/02260 Sec. 371 Date Dec. 20, 1996 Sec. 102(e) Date Dec. 20, 1996 PCT Filed Jun. 12, 1995 PCT Pub. No. WO95/35143 PCT Pub. Date Dec. 28, 1995An aqueous fatty alcohol dispersion containing: (a) 5% to 40% by weight of a Cl10-C28 fatty alcohol; (b) 0.5% to 5% by weight of anionic interfacially active compounds; (c) 0.5% to 5% by weight of nonionic interfacially active compounds comprising the reaction products of ethylene oxide with alkane-1,2-diols containing 6 to 18 carbon atoms, and (d) the balance, water. The dispersion is useful as an antifoam agent.
Patent NZ-294148-A (NZ)
Title: Isolated nucleic acid molecule coding for tumour rejection antigen precursor dage and uses thereof
Inventor: COULIE PIERRE
IPC: C12Q1/68
Filed: 1995-09-21
Abstract: A new family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as DAGE tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as GAGE coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigens, and their precursor molecules are described.
Patent NZ-328070-A (NZ)
Title: Method and apparatus for continuous processing of dairy shed waste to produce fertiliser and combustible gas
Inventor: HARLOW ROY JAY
IPC: C02F1/00
Filed: 1998-06-11
Abstract: pparatus, for the continuous processing of dairy shed waste to render it substantially non-toxic and produce a liquid fertiliser and soil conditioner, includes a substantially airtight , substantially horizontal and cylindrical tank 6 to receive and hold a predetermined quantity of waste, wherein the ratio of the length to diameter of the tank is between 5.5:1 and 4.25:1.  The tank has inlet means 8 to receive the waste and outlet means 9 for discharge of liquid fertiliser, soil conditioner and gaseous product from the tank and to maintain a predetermined pressure within the tank.  The apparatus may include a sub-tank 20 connected to tank 6, sub-tank 20 holding water which may be heated by a gas burner in a tube 10 to provide controlled temperature conditions within the environment 7 of tank 6.  A collector 17 may be provided on an upper portion of the tank for gas, a pressure release valve 18 being provided in association with the collector.
Patent NZ-332289-A (NZ)
Title: Apparatus for modifications made to a video signal to inhibit the making of acceptable videotape recordings
Inventor: RYAN JOHN O
IPC: H04N5/91
Filed: 1997-05-07
Abstract: A video signal is modified so that a television/receiver still produces a normal picture from the modified signal, whereas videotape recording of this signal produces generally unacceptable pictures. Videotape recorders have an automatic gain control circuit which measures the sync pulse level in a video signal and develops a gain control correction signal for keeping the video applied to an FM modulator in the videotape recording system at a fixed predetermined level. A portion of the back porch intervals following the trailing edges of a substantial number of sync pulses are significantly raised and lowered to improve the playability of the original signal without reducing the effectiveness of the copy protection of the copied signal. This is achieved most simply by adding pulses to selected lines of the video signal during the back porch interval, which pulses significantly raise or lower the voltage amplitude during the blanking interval so to provide a signal where the average value is approximately equal to the blanking interval. The sync level and the sync duration on the selected lines are also reduced to enhance the effectiveness of the process.
Patent NZ-335055-A (NZ)
Title: Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents and process for its production
Inventor: DENNY WILLIAM ALEXANDER
IPC: C07D219/04
Filed: 1997-10-17
Abstract: A compound which is a bis(acridinecarboxamide) or bis(phenazinecarboxamide) derivative of formula (I), wherein: X, which may be the same or different in a given molecule, is -CH= or -N= R1 to R4 which may be the same or different, H, C1-C4 alkyl, OH, SH, NH2, C1-C4 alkoxy, aryloxy, NHR, N(R)2, SR, SO2R wherein R is C1-C4 alkyl, CF3, NO2 or halogen, or R1 and R2 together form a methylenedioxy group; R5 and R6, which may be the same or different, are H or C1-C4 alkyl; Z is (CH2)n, (CH2)nO(CH2)n, (CH2)nN(R7) (CH2)n, (CH2)nN(R7) (CH2)mN(R7) (CH2)n or (CH2)nN(CH2CH2)2N(CH2)n wherein R7 is H or C1-C4 alkyl n and m, which may be the same or different, are each an integer of 1 to 4; or a pharmaceutically acceptable acid addition salt or N-oxide thereof. Also disclosed is the process for producing the above compound and its use as an anti-tumour agent.
Patent NZ-337920-A (NZ)
Title: Two-way wireless remote control including advertising display
Inventor: DARBEE PAUL
IPC: G06F3/0482
Filed: 1998-03-23
Abstract: A wireless remote control device for a piece of electronic equipment is capable of both sending and receiving information.  The information received can include advertising material.  The remote control device includes a display 14 which displays the advertising material whenever the display is not required for displaying information regarding the use of the control.  A timeout control will display the advertising material a predetermined time after the user has pressed a button.  The control may communicate using infrared or radio waves.  The remote control is intended for use with such things as cable or satellite decoder boxes, or television sets.
Patent NZ-501215-A (NZ)
Title: Treatment of thrombosis using anti-Factor IX monoclonal antibodies
Inventor: BLACKBURN MICHAEL NEAL
IPC: C12N5/06
Filed: 1997-01-17
Abstract: Anti-Factor IX monoclonal antibody that has a self-limiting neutralizing activity may be used in medicaments for inhibiting thrombosis.  Acetylsalicylic acid may optionally be used in the medicament.
Patent NZ-503200-A (NZ)
Title: Sun protection composition containing a skin cleansing agent
Inventor: POLEFKA THOMAS G
IPC: A61Q17/04
Filed: 1998-09-04
Abstract: A skin cleansing, sunprotecting composition comprising (a) an effective sun protecting amount of a sun protecting hydrophobic agent or mixture thereof, (b) a polar organic solvent of lower polarity than water, (c) an oil, and (d) a cleansing effective amount of a surfactant or mixture thereof wherein the oil/polar solvent ratio on a weight basis is about 1:4 to about 1:0.8.
Patent NZ-505651-A (NZ)
Title: Sustained release composition comprising biologically active substance, hydroxynaphthoic acid and biodegradable polymer
Inventor: SAIKAWA AKIRA
IPC: A61K9/52
Filed: 1999-01-13
Abstract: Described is a sustained-release composition containing a hydroxynaphthoic acid, a biologically active substance, and a biodegradable polymer, allowing a more controlled release of said active substance when compared in the absence of said polymer.
Patent NZ-509806-A (NZ)
Title: Pharmaceutical compositions comprising ibuprofen and domperidone
Inventor: DICKINSON JEFFREY
IPC: A61K9/22
Filed: 1999-08-04
Abstract: A stable pharmaceutical composition useful for treating migraine comprises an ibuprofen medicament and a domperidone medicament and a carrier material characterised in that the carrier material is free of povidone and comprises at least one diluent combined with at least one disintegrating agent and a granulating agent excluding a) a compressed tablet comprising  granulated ibuprofen and a carrier material consisting of 35-38% total tablet weight of maize starch with 3-4% total tablet weight of dried maize starch or 10-11% total tablet weight of microcrystalline cellulose with 14-16% total tablet weight of croscarmellose sodium and 10% total tablet weight pregelled starch; b) a direct compression tablet comprising a carrier material consisting of 8-11% total tablet weight of microcrystalline cellulose and 5-6% total tablet weight of lactose or c) a hard gelatin capsule comprising a carrier material consisting of 15-20% total capsule  weight of maize starch with 5-6% total capsule  weight of pregelled starch.
Patent NZ-512852-A (NZ)
Title: 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors
Inventor: ARORA SUDERSHAN K
IPC: C07H19/04
Filed: 2000-01-10
Abstract: This invention relates generally to compounds and processes for synthesizing derivatives of 2-3-O- isopropylidene-alpha -L-xylo-2- hexulofuranosonic acid, of formula (I) compounds of this invention are useful, inter-alia, for the inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies, including inflammatory and autoimmune diseases, such as bronchial asthma, rheumatoid arthritis, type I diabetes, multiple sclerosis, allograft rejection and psoriasis. This invention also relates to pharmacological compositions containing derivatives of 2-3-O- isopropylidene-alpha -L-xylo-2- hexulofuranosonic acid and the methods of treating such pathologies as listed above.
Patent NZ-517942-A (NZ)
Title: Single-stranded oligodeoxynucleotide mutational vectors
Inventor: METZ RICHARD A
IPC: A61K48/00
Filed: 2000-08-25
Abstract: The disclosure concerns the introduction of predetermined genetic changes in target genes of a living cell by introducing an oligodeoxynucleotide encoding the predetermined change. The oligodeoxynucleotides are effective in mammalian, avian, plant and bacterial cells. Specific end modifications that greatly increase the effectiveness of the oligodeoxynucleotides in bacteria are described. Unmodified oligodeoxynucleotides can be as effective in mammalian cells, including in vivo hepatocytes, as the modified nucleotides and can be as effective or more effective than chimeric oligonucleotides that consist of a mixture of deoxynucleotides and 2'-O-methyl ribonucleotides. Such compositions and methods are particularly useful as medicaments for ameliorating the effects of a genetic lesion.
Patent NZ-518266-A (NZ)
Title: Metal-binding compounds and uses therefor
Inventor: WINKLER JAMES V
IPC: A61P25/28
Filed: 2000-09-29
Abstract: Disclosed are pharmaceutical compositions comprising pharmaceutically acceptable carriers and peptides of formula: P1 - P2 wherein: P1 is Xaa1 Xaa2 His or Xaa1 Xaa2 His Xaa3 P2 is (Xaa4)n Xaa1 is glycine, alanine, valine, leucine, isoleucine, serine, threonine, aspartic acid, asparagines, glutamic acid, glutamine, lysine, hydroxylysine, histidine, arginine, ornithine, phenylalanine, tyrosine, tryptophan, cysteine, methionine, or alpha-hydroxymethylserine; Xaa2 is glycine, alanine, beta-alanine, valine, leucine, isoleucine, serine, threonine, aspartic acid, asparagine, glutamic acid, glutamine, lysine, hydroxylysine, histidine, arginine, ornithine, phenylalanine, tyrosine, tryptophan, cysteine, methionine, or alpha-hydroxymethylserine; Xaa3 is glycine, alanine, valine, lysine, arginine, ornithine, aspartic acid, glutamic acid, asparagine, glutamine or tryptophan; Xaa4 is any amino acid: and n is 0-10. The compositions are used in the manufacture of medicaments for reducing the damage done by reactive oxygen species in an animal, or for reducing the concentration of a metal in an animal.
Patent NZ-524230-A (NZ)
Title: Identification of tumor antigens the expression of which is selectively enhanced by retinoid treatment
Inventor: TICE DAVID
IPC: A61P43/00
Filed: 2001-07-10
Abstract: A method, for the selective enhancement of the expression of a protein in a tumour cell characterised by aberrant Wnt signalling, comprises treating the tumour cell with an effective amount of a retinoid.
Patent NZ-524478-A (NZ)
Title: Arginine salt of perindopril ((2S)-2-[(1S)-carbethoxybutylamino]-1-oxo-propyl-(2S, 3aS, 7aS)perhydroindole-carboxylic acid) and pharmaceutical compositions containing it
Inventor: DAMIEN GERARD
IPC: A61P9/12
Filed: 2003-02-28
Abstract: The specification relates to arginine salt of perindopril or its hydrates. The use of the arginine salt of perindropril as the active ingredient in a pharmaceutical composition is claimed, specifically when the medicament is in the form of an immediate release tablet for the treatment of hypertension and heart failure.
Patent NZ-525284-A (NZ)
Title: Cement render system
Inventor: NAJI BASIL
IPC: E04F13/02
Filed: 2001-09-19
Abstract: A method for applying render to a substrate, said method including the steps of: securing a layer of confining mesh having a three-dimensional open cellular structure to the substrate; applying a base layer of cementitious material over the confining mesh; and screeding the base layer to a depth at least substantially level with an outer surface of the confining mesh. Preferably, the method includes the further step of: applying a layer of reinforcing mesh over the base layer; and applying a top coat of cementitious material over the reinforcing mesh. A cementitious plaster formulation for use in the method as defined in the method according to any one of claims 1 to 25, said formulation including: 10 % to around 40 % cement by weight of total dry ingredients; 50 % to around 85 % sand by weight of total dry ingredients; 5 % to around 40 % fly ash by weight of total dry ingredients; an air entraining agent and a thickener respectively combined in a ratio of from 1:1 to around 120:1 and in a combined amount of between 0.01 % and around 10 % by weight based on the weight of the cement; and sufficient water to provide suitable fluidity.
Patent NZ-525552-A (NZ)
Title: SN-38 lipid complexes with cardiolipin and methods of use for the treatment of cancers and multiple sclerosis
Inventor: AHMAD IMRAN
IPC: A61K47/48
Filed: 2001-11-09
Abstract: Compositions for improving the solubility of SN-38 are described. The compositions can comprise a compound selected from SN-38 or a chemical in equilibrium with SN-38, and a lipid wherein the lipid comprises cardiolipin, and about 70% or more of the compound is in complex with the a portion of the lipid. Also described is a method of forming a lipid composition comprising SN-38 by forming a lipid phase and then hydrating the lipid phase with an alkaline aqueous solution including the compound to form the lipid composition including the compound. The composition can be used in the manufacture of a pharmaceutical for treating disease such as cancer and multiple sclerosis.
Patent NZ-526716-A (NZ)
Title: Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
Inventor: DAS JAGATTARAN
IPC: C07D417/10
Filed: 2001-12-26
Abstract: Disclosed are compounds of the general formula (I); wherein R1 represents halo, azido, isothiocyanate, thioalcohol, OR4 NHR4 or N(R4)2, where R4 represents hydrogen atom, or substituted or unsubstituted groups selected from acyl, thioacyl, (C1-C6)alkoxycarbonyl, (C3-C6)cycloalkoxythiocarbonyl, (C2-C6)alkenyloxycarbonyl, (C2-C6)alkenylcarbonyl, aryloxycarbonyl, (C1-C6)alkoxythiocarbonyl, (C2-C6)alkenyloxythiocarbonyl, aryloxythiocarbonyl, -C(=O)-C(=O}-alkyl, -C(=O)-C(=O)-aryl, -C(=O)-C(=O)-alkoxy, -C(=O)-C(=O)-axyloxy, -(C=S)-S-alkyl, -(C=S)-NH2, -(C=S)-NH-alkyl, -C(=S)-N-(alkyl)2, -C(=S)-NH-alkenyl, (C=S)-(C=O)-alkoxy, -(C=S)-(C=O)-aryloxy, -C(=S)-O-(C=O)-alkyl, C(S)-C(=S) alkyl, -C(=S)-C(=S)-aryl, thiomorpholinylthiocarbonyl or pyrrolidinyithiocarbonyl; R1 and R2 are same or different and independently represent hydrogen, halogen atom, (C1- C6)alkyl group, halo(C1- C6)alkyl, cyano, nitro, SRa, NRa, or ORa; Z represents S, O, =CH or NRb Y1 represents =O or =S group and Y2 and Y3 independently represent hydrogen, halogen, cyano, nitro, formyl, hydroxy, amino, =O, =S group, or substituted or unsubstituted groups selected from (C1-C6)alkyl, hydroxy(C1-C6)alkyl, (C1-C6)alkoxy(C1-C6)alkyl, (C1-C6)alkoxycarbonyl, carboxy(C1-C6)alkyl, (C1-C6)alkylsulfonyl, (C1-C6)alkylcarbonylamino(C1-C6)alkyl, arylcarbonylamino(C1-C6)alkyl, (C1-C6)alkylcarbonyloxy(C1-C6)alkyl, amino(C1-C6)alkyl, mono(C1-C6)alkylamino, di(C1-C6)alkylamino, arylamino, (C1-C6)alkoxy, aryl, aryloxy, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl or heterocycloalkyl; Y2 and Y3 when present on adjacent carbon atoms together also form a substituted or unsubstituted 5 or 6 membered aromatic or non-aromatic structures, optionally containing one or two heteroatoms. Further disclosed are processes for their production, intermediates used therein, and the use of the compounds of formula (I) in the manufacture of a medicament for the treatment of a bacterial infection.
Patent NZ-530441-A (NZ)
Title: Method of cryopreserving selected sperm cells
Inventor: SCHENK JOHN
IPC: C12N5/06
Filed: 2000-11-22
Abstract: A method for the cryopreservation of sperm, comprising: (a) obtaining a selected sperm sample, (b) cooling the selected sperm sample, (c) isolating sperm from the selected sperm sample to produce isolated sperm, (d) adding final extender to the isolated sperm to produce a suspension of sperm, (e) achieving an appropriate concentration of the suspension of sperm for freezing, and (f) freezing the suspension of sperm.